Alpha-Blockers For High Blood Pressure: Types, Side Effects, Drug Interactions
Conclusion
To summarize, the treatment of hypertension is a critical aspect of healthcare due to its significant impact on cardiovascular health.
While natural supplements and lifestyle modifications are important for overall well-being, the use of chemical drugs in managing hypertension remains necessary.
Chemical drugs for hypertension have undergone extensive research and have been proven effective in lowering blood pressure levels.
Alpha-blockers offer a targeted approach to address the specific mechanisms involved in hypertension, allowing for precise blood pressure control.
They work by inhibiting the ...
Source: The EMT Spot - July 17, 2023 Category: Emergency Medicine Authors: Michael Rotman, MD, FRCPC, PhD Tags: Blood Pressure Source Type: blogs
The Complicated Prostate: Cancer Is a Concern but There's More to Consider
Most younger men don’t spend a lot of time considering the health of their prostate. However, around the age of 50, they’ll likely find that their physicians want to check out prostate health both physically and through blood work known as a prostate-specific antigen (PSA) test. The PSA is not a perfect test, but it’s still used to help detect prostate cancer since there aren’t many alternatives.
National Prostate Cancer Awareness Month is meant to increase the knowledge about possible prostate problems and make certain that men get checked out regularly.
What is the prostate?
The prostate is a small organ locat...
Source: Minding Our Elders - September 7, 2022 Category: Geriatrics Authors: Carol Bradley Bursack Source Type: blogs
Catheter-Free Urodynamics Testing: Interview with Derek Herrera, CEO at Bright Uro
Bright Uro, a medtech company based in California, has created the Glean Urodynamics System, a catheter-free urodynamics testing system. At present, urodynamics testing can help clinicians to diagnose and assess patients with lower urinary tract symptoms, including a frequent urge to urinate and incontinence. The procedure typically involves inserting a catheter into the bladder and another into the vagina or rectum.
The test can provide information on how well the bladder can store and empty urine. However, the need for two catheters means that a patient must lie in place as the test is ongoing, and does not allow clin...
Source: Medgadget - August 19, 2022 Category: Medical Devices Authors: Conn Hastings Tags: Exclusive Urology Bright Uro Urodynamics Urodynamics testing Source Type: blogs
Urolift Advanced Tissue Control to Treat Benign Prostatic Hyperplasia
Teleflex has launched the Urolift Advanced Tissue Control system, a product designed to treat patients with benign prostatic hyperplasia (BPH). The system can be used to open the urethra by inserting small implants that hold the lobes of the prostrate in a retracted position. The device is specifically tailored to treat those with challenging prostatic anatomy, including those with large lateral lobes and an obstructive median lobe.
BPH is a common condition affecting perhaps over 500 million men globally, and it often occurs with increasing age. For men who are affected, it can lead to a decreased quality of life. Trea...
Source: Medgadget - November 2, 2020 Category: Medical Devices Authors: Conn Hastings Tags: Urology Source Type: blogs
The Management Script in Action: Putting a Practical Tool to Work
In our recent Academic Medicine Perspective, we proposed the term “management script” as a concept for teaching management reasoning. Analogous to the illness script, an essential component of diagnostic reasoning, management scripts are high-level, precompiled, conceptual knowledge structures of the courses of action that a clinician might undertake to address a patient’s health care problem(s). Not to be confused with a checklist, where specific interventions are mandated in a sequence, management scripts are more like a menu: a collection of options in various categories (e.g., appetizers, courses, des...
Source: Academic Medicine Blog - August 4, 2020 Category: Universities & Medical Training Authors: Guest Author Tags: Featured care management decisions clinical decision making residency training residents Source Type: blogs
iTind for Benign Prostatic Hyperplasia Gets FDA Green Light
Medi-Tate, based in Israel, has won FDA de novo authorization for its iTind system to treat benign prostatic hyperplasia. The minimally invasive system is used to implant and remove a nitinol device, during a five day outpatient procedure, which is used to continually push on the prostatic urethra and bladder neck to remodel them.
The ischemic response to the application of pressure from the three pressure ridges of the implant creates three new channels within the tissue. This helps urine to flow out much easier and the procedure doesn’t leave anything behind once the implant is removed.
Olympus, which seems...
Source: Medgadget - March 6, 2020 Category: Medical Devices Authors: Medgadget Editors Tags: Urology Source Type: blogs
Switching to Outpatient Surgery for Everyone ’s Benefit
By AMY KRAMBECK, MD
The
trend toward less invasive procedures, shifting from inpatient to outpatient, has
changed the face of surgery. Industry-changing leaps in technology and surgical
techniques have allowed us to achieve our treatment goals with smaller
incisions, laparoscopy and other “closed” procedures, less bleeding, less pain,
and lower complication rates. As a result, patients who used to require days of
recovery in the hospital for many common surgeries can now recuperate in their
own homes.
Outpatient
procedures grew from about 50% to 67% of hospitals’
total surgeries between 1994 and 2016,1,2 and o...
Source: The Health Care Blog - December 19, 2019 Category: Consumer Health News Authors: Christina Liu Tags: Medical Practice Physicians Amy Krambeck benign prostatic hyperplasia outpatient surgery Source Type: blogs
Injectable Hydrogel for Transcatheter Intravascular Embolization: Interview with Dr. Rahmi Oklu, Founder of Obsidio
Obsidio Inc., a medical device company
based in Columbia, South Carolina, has developed an embolic hydrogel (called a
gel embolic material: GEM) designed to be delivered minimally invasively
through a clinical catheter for blood vessel occlusion. Applications include
controlling blood flow in vascular injuries and aneurysms, reducing tumor blood
supply, and preventing abnormal blood flow between arteries and veins, such as
arteriovenous malformations.
Currently,
the gold standard treatment in terms of transcatheter embolization involves
delivering multiple metal coils into a blood vessel, which works by promoting
coagul...
Source: Medgadget - September 6, 2019 Category: Medical Devices Authors: Conn Hastings Tags: Cardiac Surgery Exclusive Neurosurgery Oncology Vascular Surgery Source Type: blogs
Q & A with Dr. Daniel Rukstalis on prostatic urethral lift for enlarged prostates
A new procedure that relieves symptoms without causing sexual side effects
As men get older, their prostates often get bigger and block the flow of urine out of the bladder. This condition, which is called benign prostatic hyperplasia, causes bothersome symptoms. Since men can’t fully empty their bladders, they experience sudden and frequent urges to urinate. Treatments can relieve these symptoms, but not without troubling side effects: pharmaceutical BPH treatments cause dizziness, fatigue, and retrograde ejaculation, meaning that semen gets diverted to the bladder during orgasm instead of being ejected from the body. S...
Source: Harvard Health Blog - October 25, 2018 Category: Consumer Health News Authors: Charlie Schmidt Tags: BPH Prostate Knowledge Q & A HPK Source Type: blogs
Embolx Announces FDA Clearance for Next Generation Sniper Balloon Occlusion Microcatheter
Embolx, a new medical device company out of Silicon Valley, develops microcatheters for arterial endoembolization procedures, and now their next-generation Sniper Balloon Occlusion Microcatheter will be available in the US. The new family of microcatheters shows significant improvement over previous devices, and offers physicians enhanced performance features to make it easier to navigate through small vascular structures.
The Embolx Sniper’s balloon occludes the vessel to alter blood flow-dynamics using a method called pressure-directed embolization (see video below). It is currently used for the treatment of cancer...
Source: Medgadget - July 5, 2018 Category: Medical Devices Authors: Yuriy Sarkisov Tags: Oncology Radiology Surgery Source Type: blogs
We heard you — incontinence affects men too. Here’s what you need to know
As men age, the simple act of urinating can get complicated. Prostate surgery often leaves men vulnerable to leakage when they cough, sneeze, or just rise from a chair. Or the bladder may become impatient, suddenly demanding that you find a bathroom right now. “Thousands of years ago, it was not as much of an issue,” observes Dr. Anurag Das, a urologist at Harvard-affiliated Beth Israel Deaconess Medical Center. “There were lots of trees, and you could just find one and go.”
But tricky bladders can be whipped into shape. The first step is a careful assessment of what triggers those difficult moments. Often your doc...
Source: Harvard Health Blog - November 8, 2017 Category: Consumer Health News Authors: Matthew Solan Tags: Health Healthy Aging Incontinence Men's Health Prostate Health Source Type: blogs
Interventional Radiology Takes on a New Condition
An enlarged prostate can seriously impede daily life functions. Benign prostate hyperplasia, or an enlarged prostate affects 80 percent of males, and that same percentage experience complications such as urinary retention and kidney damage. Traditional remedies include invasive surgery, cutting the tissue out, and other advancements that diminish the prostate ’s size by using lasers or microwave energy. Although these procedures are usually effective, they result in bleeding, urinary incontinence, and extensive recovery time that take weeks.Assistant professor of radiology at Yale University, Raj Ayyagari, MD, has develo...
Source: radRounds - June 10, 2017 Category: Radiology Authors: Julie Morse Source Type: blogs
NxThera ’s Rezūm Provides a New Treatment Option for Patients with BPH: Interview with CEO of NxThera
Benign prostatic hyperplasia (BPH), or enlargement of the prostate gland, affects about half of men between the age of 51 and 60 and up to 90% of men over the age of 80. Symptoms include difficulty with initiating urination, weak urine flow, post-void dribbling, and the need to wake up frequently during the night to urinate. Not only are these symptoms bothersome and negatively affect an individual’s quality of life, they may also lead to more serious conditions like bladder stones, urinary tract infections, or bladder and kidney damage. Unfortunately, many people with BPH choose to live with their symptoms due to the li...
Source: Medgadget - November 10, 2016 Category: Medical Equipment Authors: Kenan Raddawi Tags: Exclusive Urology Source Type: blogs
